About Us

Global Scientific Conferences invites all the participants across the globe to attend the Global Congress & Expo on Pharmacy during June 13th -14th, 2018 which is to be held in Dubai UAE.Pharmacy 2018 provides a unique networking opportunities for researchers and practitioners from all around the world to share the latest research and advancement in the field of pharmacy practice and learn from each other.In the light of this theme, the conference series aims to provide a forum for International researchers from various areas of Pharmacy, Medical, Health science and Life science by providing a platform for critical analysis of new data, and to share latest cutting-edge research findings and results about all aspects of pharmacy.This conference is a global platform to discuss and learn about exchange research evidence, innovative ideas and models of best practice. The conference organizing committee is confident that participants will benefit from the high value scientific program. 

Pharmacy Speakers

Global Scientific Conferences  brings you an immense opportunity to be a part of scientific acceleration to world class personalities, young scholars, scientific delegates and young scientists to join in this forum to utilize the expertise and novelties that brings a new era for innovations in the fields of Pharmacy .which brings well versed scrutinizers at one place. It provides a platform to have open discussions, knowledge sharing and interactive sessions with field experts at Pharmacy 2018.

We request you to submit a brief idea or abstract of your talk/presentation/symposium/workshop according to your session interest. Please follow the format of our Sample Template.

Sessions & Tracks

Track 1: Pharmaceutical Sciences

Disease is the enemy of mankind, which affects part or all of organism.  Efforts to cure or improve the health condition against disease lead a remarkable improvement in pharmaceutical sciences. Pharmaceutical science is a wide range of combinations of scientific disciplines that contribute to the discovery and development of new drugs and therapies. Advancements in the branches of pharmaceutical sciences enhance the development of new reliable entities. Every aspect of the pharmaceutical science deals with the drug design, drug action, drug delivery, and drug disposition. According to the 2015 EU Industrial R&D Investment Scoreboard the pharmaceutical and biotechnology sector amounts to 18.2pecent of total business R&D expenditure worldwide. On the other side Europe drug manufacturing is 225000 €millions and exports were 361500 €millions. Europe spent 31,500 €millions on R&D in 2015 while US spent 47,061 €millions.

Track 2: Drug Discovery and Research

Persistent innovative development is one of the eminent characters of pharmaceutical industry. Pharmaceutical innovation is an orderly, predictable process. Intensive research coverage is resulting in an abundant knowledge of the mechanisms driving drug discovery and development. The invention of new medicines and the improvement of existing drugs constitute the development firms in this industry. The occasional triumph of creating a novel drug therapy in an area with no prior treatments counts among the pharmaceutical industry’s most defining hallmarks. Germany is forecast to have highest increase in market value at € 11.4bn. Novartis is forecast to reduce its R&D spending, from $10.5bn in 2020 to only $9.2bn in 2022. Of the top 20, Celgene and Regeneron are forecast to grow their R&D expenses most rapidly, with R&D spend forecast to increase 11percent  per year until 2022. Overall, total R&D spends is expected to increase by 2.8percent  each year, reaching $182bn in 2022.

Track 3: Biopharmaceutics: Drug Discovery and Development

The field of new drug development has moved its focus from small-molecule compounds to large-molecule proteins and other biopharmaceuticals. These biopharmaceuticals have caused an archetype shift in disease cure and has led to an enhancement in the quality of life of patients with various diseases such as autoimmune diseases, refractory cancers  biopharmaceuticals represent 7.5percent  of all drugs in the market and account for ~10percent of the total expenses for marketed drugs. The usage of biopharmaceuticals are increasing at the rate >20percent per year. They are already being used74percent more than chemically derived pharmaceuticals, in life-saving or end-stage applications . Moreover, biopharmaceuticals covers > 30percent of all pipeline research programs going-on at present

which embraces all recombinant proteins, monoclonal antibodies, cytokines, peptides, vaccines, blood/plasma-derived products, non-recombinant culture-derived proteins, nucleic acid-based products (DNA, RNA or antisense oligonucleotides used for curative or in vivo diagnostic purposes), cells and tissues cultures. This view is possibly best understood by the public and mostly used by the people in the biopharmaceutical

Track 4: Innovations In Drug Development

Drug development involves enormous methods and development procedure to attain therapeutic effective level. Emerging new pharmaceutical formulation is a persistent process with utilization of abundant knowledge of pharmaceutics. Considering all characteristics of substances used, and their behavior towards formulations need more innovative approach of drug development. The global market value for drug development technologies market share was about 30pecent in 2015 valued at $18 billion followed by Bio analytical Assays or instruments by about $14 billion. Innovative formulations are estimated to have contributed to 73percent. To develop a new pharmaceutical formulation and to conduct clinical trials it cost at € 1,926 million in 2016.

Track 5: Pharmaceutical Formulations

Pharmaceutical formulations is extensive procedure involving  characterization of a drug’s physical, chemical, and mechanical properties in order to choose what other ingredients (excipients) should be used in the preparation and resulting a safe and efficacy product. Modern pharmaceutical formulation is expanding its sector with technology and innovation to formulate eminent result oriented formulations. The global pharmaceutical excipients market is projected to reach USD 8.1 Billion in 2021 at a CAGR of 6.1percent  in the forecast period 2016 to 2021. The rising demand for new drug delivery systems, greater understanding of the functional benefits of excipients, growing pharmaceutical industry, and patent expiries of several blockbuster drugs are positively impacting the overall growth of the market.

Track 6: Pharmaceutical Analysis

Producing safe and effective formulation is the main goal for Pharmaceutical industry. Hence pharmaceutical industry has great concern towards impurities due to their adverse effects. The trends in pharmaceutical analysis focuses on the modern methods, technology  and tools for control of  related impurities, and faster analysis time, better separation  time and faster method development.

Track 7: Pharmacology and Pharmacovigilance:

Pharmacology is the branch of medicine and biology concerned with the study of drug action, where a drug can be broadly defined as any man-made, natural, or endogenous (from within body) molecule which exerts a biochemical and/or physiological effect on the cell, tissue, organ, or organism (sometimes the word pharmacon is used as a term to encompass these endogenous and exogenous bioactive species). More specifically, it is the study of the interactions that occur between a living organism and chemicals that affect normal or abnormal biochemical function. If substances have medicinal properties, they are considered pharmaceuticals.

Pharmacovigilance, also known as drug safety, is the pharmacologicalscience relating to the collection, detection, assessment, monitoring, and prevention of adverse effects with pharmaceutical products. The etymological roots for the word “pharmacovigilance” are: pharmakon (Greek for drug) and vigilare (Latin for to keep watch). As such, pharmacovigilance heavily focuses on adverse drug reactions, or ADRs, which are defined as any response to a drug which is noxious and unintended, including lack of efficacy (the condition that this definition only applies with the doses normally used for the prophylaxis, diagnosis or therapy of disease, or for the modification of physiological disorder function was excluded with the latest amendment of the applicable legislation). Medication errors such as overdose, and misuse and abuse of a drug as well as drug exposure during pregnancy and breast feeding, are also of interest, even without an adverse event, because they may result in an adverse drug reaction.

Track 8: Regulatory Affairs & Intellectual Property Rights

Regulatory Affairs has a very specific meaning within the healthcare industries. Its regulations are for systematic manufacturing and marketing of safe, efficacious and qualitative drugs. Improving new regulations and adapting to the technology regulatory affairs set new goals and challenges to the pharmaceutical formulation. The global regulatory affairs outsourcing market had a valuation of US$1.9 bn in 2014. The market is expected to expand at a substantial 11.5percent  CAGR from 2015 to 2023 and rise to a valuation of US$5.7 billion by 2023.

Track 9: Ethics In Pharmacy

Pharmacy is a healthcare profession assisting individual in making the best use of medicine. Ethics are intended to state publicly the principles that form the fundamental basis of the roles and responsibilities of pharmacists. Spending on specialty drugs in 2012 in the United States was about $87 billion. Estimates suggest that it could quadruple by 2020, reaching about $400 billion.

Track 10: Cellular and Gene Therapy

Cell therapy as performed by alternative medicine practitioners is very different from the controlled research done by conventional stem cell medical researchers. Alternative practitioners refer to their form of cell therapy by several other different names including Immunotherapy, Allogenic Cell Therapy and fresh Neural Stem cell therapy. Proponents of cell therapy claim that it has been used successfully to rebuild damaged cartilage in joints, repair spinal cord injuries,strengthen a weakened immune system, treat autoimmune diseases such as AIDS, and help patients with neurological disorders such as Alzheimer’s disease, Parkinson’s disease and epilepsy.

Gene therapy and cell therapy are overlapping fields of biomedical research with the goals of repairing the direct cause of genetic diseases in the DNA or cellular population, respectively. The development of suitable gene therapy treatments for many genetic diseases and some acquired diseases has encountered many challenges and uncovered new insights into gene interactions and regulation. Further development often involves uncovering basic scientific knowledge of the affected tissues, cells, and genes, as well as redesigning vectors, formulations, and regulatory cassettes

Track 11: Biologics and Biosimilars

The development of biologics calls for overcoming lot many challenges. With initial steps of concepts of biologics, their considerations, essentials for early clinical developments it is very much needed that proper scientific and strategic approaches are taken for the successful development of follow-on-biologics. Moreover, the need for overcoming the challenges continues in the late clinical steps, drug safety factors and labelling requirements. Also it is much required now to develop a drug product in accordance to quality by design (QbD). This Euro Biopharma 2017 conference will look at the multiple facets of current challenges in biosimilar development. This conference will focus on multiple aspects of biosimilar product development to successfully deliver safe, potential and efficacious biologic products to the market

Track 12: Bio Pharmaceuticals:

A biopharmaceutical, also known as a biological medical product, biological, or biologic, is any pharmaceutical drug product manufactured in, extracted from, or semi synthesized from biological sources. Different from totally synthesized pharmaceuticals, they include vaccines, blood, blood components, allergenic, somatic cells, gene therapies, tissues, recombinant therapeutic protein, and living cells used in cell therapy. Biologics can be composed of sugars, proteins, or nucleic acids or complex combinations of these substances, or may be living cells or tissues. They (or their precursors or components) are isolated from living sources—human, animal, plant, fungal, or microbial.

Terminology surrounding biopharmaceuticals varies between groups and entities, with different terms referring to different subsets of therapeutics within the general biopharmaceutical category. Some regulatory agencies use the terms biological medicinal products or therapeutic biological product to refer specifically to engineered macromolecular products like protein- and nucleic acid-based drugs, distinguishing them from products like blood, blood components, or vaccines, which are usually extracted directly from a biological source. Specialty drugs, a recent classification of pharmaceuticals, are high-cost drugs that are often biologics. Gene-based and cellular biologics, for example, often are at the forefront of biomedical research, and may be used to treat a variety of medical conditions for which no other treatments are available..

Track 13: Medical Device & Combination Products Regulations

Blend items are remedial and indicative items that consolidate medications, gadgets, and/or organic items. FDA hopes to get expansive quantities of blend items for audit as innovative advances keep on merging item sorts and obscure the verifiable lines of partition between FDA’s therapeutic item focuses, which are comprised of the Center for Biologics Evaluation and Research (CBER), the Center for Drug Evaluation and Research (CDER), and the Center for Devices and Radiological Health (CDRH). Since mix items include parts that would regularly be controlled under various sorts of administrative powers, and much of the time by various FDA Centers, they raise testing administrative, strategy, and audit administration challenges. Contrasts in administrative pathways for every part can affect the administrative procedures for all parts of item improvement and administration, including preclinical testing, clinical examination, showcasing applications, assembling and quality control, antagonistic occasion reporting, advancement and promoting, and post-endorsement alterations.

Track 14: Entrepreneurs’ investment meet

The life sciences sector’s growth correlates highly with countries’ general economic strength and health care spending levels, and both of these vary widely around the globe. In 2015 North America accounted for 48.7percent of world pharmaceutical sales compared with 22.2percent for Europe. According to IMS Health data, 58percent of sales of new drug discovery made during the period 2010–2015 were on the US market, compared with 23percenet on the European market. Europe is ensuring competitive growth along with other countries.  By 2022, products currently in drug development will account for 17percent of sales in Europe. Europe is expected to show a 3percent CAGR 2016-22, mainly driven by the launch of new products currently in development. The penetration of biotech products is set to increase from a 24percent market share in 2015 to 29percent in 2022.

Track 15: Current GMP Guidelines (cGMP) & GxP in Pharmaceuticals

CGMP refers to the Current Good Manufacturing Practice regulations enforced by the US FDA. CGMPs provide for systems that assure proper design, monitoring, and control of manufacturing processes and facilities. Adherence to the cGMP regulations assures the identity, strength, quality, and purity of drug products by requiring that manufacturers of medications adequately control manufacturing operations. This includes establishing strong quality management systems, obtaining appropriate quality raw materials, establishing robust operating procedures, detecting and investigating product quality deviations, and maintaining reliable testing laboratories.

The purpose of the GxP quality guidelines is to ensure a product is safe and meets its intended use. GxP guides quality manufacture in regulated industries including food, drugs, medical devices and cosmetics.

Track 16: Good Clinical Practices & Good Laboratory Practices

The role of ICH in designing GCP principles is to provide an ethical treatment to the subjects who are involved in the clinical trials. Conference on Good Clinical Practices is important because it is an international ethical and scientific quality standard for designing, conducting, recording and reporting trials that involve the participation of human subjects. The GLP Principles describe requirements for and provide general guidance on the conduct of all nonclinical health and environmental safety studies, including invitro studies. Pre-clinical trials assess the toxicity of a drug and examine its potential effects on the human body. These trials are conducted in-vitro which is required to proceed with clinical trials. Good laboratory practices should be followed for these pre-clinical trials.

Track 17: Pharmaceutical Toxicology

Pharmaceutical Toxicology explains the methodology and requirements of pre-clinical safety assessments of new medicines. With the focus on medicinal drugs, the most important safety issues of drugs are covered. This includes registration requirements of new drugs and pharmacovigilance.

Pharmaceutical Toxicology is focusing on the diagnosis, management and prevention of poisoning and other adverse health effects due to medications, occupational and environmental toxicants, and biological agents. Medical toxicologists are involved in the assessment and treatment of acute or chronic poisoning, adverse drug reactions (ADR), overdoses, envenomation’s, and substance abuse, and other chemical exposures.

Track 18: Industrial Pharmacy

Industrial Pharmacy also plays a crucial role in any drug discovery. To any novel drug discovery the industrial approach is very important to get massive commercial application. Few things which have to be considered by industries to provide a safe and cost affective medicine to the patients like Supply chain, Waste management, Product management, Post- marketing surveillance, Good manufacturing practices and Marketing.

The U.S. pharmaceutical market is the world’s most important national market. Together with Canada and Mexico, it represents the largest continental Pharma market worldwide. The United States alone holds some 40 percent of the global pharmaceutical market. In 2014, this share was valued around 365 million U.S. dollars. Many of the global top companies are located in the United States. In 2014, six out of the top eleven companies were U.S.-based.

Track 19: Good Clinical Practices & Good Laboratory Practices

The role of ICH in designing GCP principles is to provide an ethical treatment to the subjects who are involved in the clinical trials. Conference on Good Clinical Practices is important because it is an international ethical and scientific quality standard for designing, conducting, recording and reporting trials that involve the participation of human subjects. The GLP Principles describe requirements for and provide general guidance on the conduct of all nonclinical health and environmental safety studies, including invitro studies. Pre-clinical trials assess the toxicity of a drug and examine its potential effects on the human body. These trials are conducted in-vitro which is required to proceed with clinical trials. Good laboratory practices should be followed for these pre-clinical trials.

Track 20: QC & QA: Quality control and Quality assurance:

With greater attention to the following elements this session will discuss the all the key lookouts essential for the development of a QA/QC system in pharmaceutical manufacturing process and requires implementation in tracking inventory compilation:

  • An inventory agency responsible for coordinating QA/QC activities;
  • A QA/QC plan;
  • General QC procedures
  • Source category-specific QC procedures
  • QA review procedures;
  • Reporting, documentation, and archiving procedures.

Market research analysts predict that the global automated industrial quality control (QC)  market will grow steadily at a CAGR of around 8 percent by 2021.

Global Scientific Conferences organizing eminent Pharmaceutical conferences welcomes you to attend the Global Congress & Expo on  Pharmacy to be held during June 13th-14th, 2018 at Dubai,  focuses on the advancements in pharmacy .

The field of Pharmacy is growing rapidly and its development is making tremendous impacts in Global world of pharmaceuticals.  Emphasizes on how the importance and significance can be gauged by the fact that it has made huge advancements over the course of time and is continuing to influence various sectors.

Pharmacy 2018 is a remarkable event which brings together a unique and International mix of large and medium Pharmaceutical companies / industries, leading universities and research institutions making the conference a perfect platform to share experience, foster collaborations across industry and academia, and evaluate emerging technologies across the globe. The conference provides a platform to critically analyze and understand the methods and mechanisms.

The main theme of the Pharmacy 2018 conference is : Innovations in Exertions of Pharmacy

Global Congress & Expo on Pharmacy (Pharmacy 2018) is anticipating around 300 participants around the globe and the two day conference will provoke Plenary sessions, Keynote speeches, Poster, and Oral presentations. 

Why to Attend???

Meet Your Target Market with members from around the world focused on learning about Pharmaceutical Sciences and Medicinal Chemistry, this is your single best opportunity to reach the largest assemblage of participants from the Pharma and medicinal community, Find out how innovators are closing the gap between product development and adoption, Better identify cyber threats and reduce information security risks, Debate the potential to greater cross-industry and cross-sector collaboration in the race for faster, cheaper, better cures. Conduct demonstrations, distribute information, meet with current and potential Scientists, make a splash with a new research, and receive name recognition at this 2-day event Pharmaceutical Science & Medicinal Chemistry. World-renowned speakers, the most recent techniques, tactics, and the newest updates in Pharmaceutical Sciences fields are hallmarks of this conference.

A Unique Opportunity for Advertisers and Sponsors at this International event:

Target Audience:

  • Professors, Associate Professors, Assistant Professors
  • PhD Scholars
  • Graduates and Post Graduates
  • Directors, CEO’s of Organizations
  • Association, Association presidents and professionals
  • Noble laureates in Health Care and Medicine
  • Bio instruments Professionals
  • Bio-informatics Professionals
  • Software development companies
  • Research Institutes and members
  • Supply Chain companies
  • Manufacturing Companies
  • CRO and DATA management Companies
  • Training Institutes
  • Business Entrepreneur
  • Government healthcare departments, HTA’s and drug regulators
  • Digital health companies
  • Genomics and personalised medicine experts

Scope and Importance:

Pharmaceutical Technology is a latest technological platform to aid efficient drug discovery and development. These platforms range from vast chemical libraries, ultra-high throughput screening and huge genetic databases in discovery, to predictive toxicology platforms and even deep-seated knowledge of particular therapeutic areas in development. New research platforms designed to help its teams of investigators focus on a set of key strategic initiatives that will help guide their multi billion-dollar drug development program to advance new medicines that can get ahead of a disease and prevent it from taking a toll .Pharmaceutical research indulges in making medicines from plant- and chemical-based compounds. They work to prevent the spread of disease, ease pain, cure illnesses, and slow the effects of aging, among many other things. Pharmaceutical companies’ mission to discover the next ground breaking medicine is a big cause steeped in big bucks, big competition, and, at times, big controversy. Insiders refer to the handful of multinational giants that dominate the industry-Pfizer and Glaxo Smith Kline, to name two of the largest-as Big Pharma.

About venue:-

Dubai is the most crowded city in the United Arab Emirates (UAE). It is situated on the southeast shore of the Persian Gulf and is one of the seven emirates that make up the nation. The city of Dubai is situated on the emirate’s northern coastline and heads up the Dubai-Sharjah-Ajman metropolitan territory. Dubai is to host World Expo 2020.

Dubai has risen as a worldwide city and business center of the Middle East. It is additionally a noteworthy transport center for travelers and payload. By the 1960s, Dubai’s economy depended on incomes from exchange and, to a littler degree, oil investigation concessions, yet oil was not found until 1966. Oil income initially began to stream in 1969. Dubai’s oil income quickened the early advancement of the city, yet its stores are constrained and creation levels are low: today, under 5 percent  of the emirate’s income originates from oil. The emirate’s Western-style model of business drives its economy with the primary incomes now originating from tourism, flying, land, and monetary administrations. Dubai has as of late pulled in world consideration through numerous imaginative vast development undertakings and games occasions. The city has turned out to be notorious for its high rises and elevated structures, specifically the world’s tallest building, the Burj Khalifa.

Dubai gives a world class instruction and furthermore gigantic openings for work. The most understood colleges in Dubai are American University in Dubai, Hult International Business School, Al Ghurair University, The American College of Dubai, University of Wollongong in Dubai, British University in Dubai offering courses in Business Administration, Engineering, Architecture and Interior Design.

American University in Dubai is one of the six UAE colleges highlighted in QS World University Rankings 2014/2015. In 2013 Synergy University Dubai Campus opened its grounds in Jumeirah Lakes Towers being a first University in Dubai to situated outside of Educational Zones.

Societies Associated with United Arab Emirates:-

  • Aweer Society Pharmacy
  • Safa Society Pharmacy
  • 5th International Congress of the Emirates Neurology Society (EMINS).
  • Aster Al Aweer Pharmacy
  • International Society of Oncology Pharmacy Practitioners
  • Emirates Pharmacy Society (EPS)
  • Health Authority of Abu Dhabi
  • Department of Health and Medical Services of Dubai
  • Abu Dhabi Health Services
  • Secretariat General Health
  • Dubai Health Authority
  • UAE Pharmacy Society
  • Emirates Medical Association Pharmacy Society
  • International Pharmaceutical Students’ Federation (IPSF)
  • European Association of Employed Community Pharmacists in Europe (EPhEU)
  • European Pharmaceutical Union (EPU)
  • Pharmaceutical Group of the European Union (PGEU)
  • Australian College of Pharmacy
  • Pharmaceutical Society of Australia
  • The Pharmacy Guild of Australia
  • The Society of Hospital Pharmacists of Australia
  • Canadian Pharmacists Association
  • Canadian Society of Hospital Pharmacists
  • Chinese Pharmaceutical Association
  • Danish Association of Pharmaconomists
  • Indian Pharmacist Association
  • Pharmaceutical Society of Ireland
  • The Pharmaceutical Association of Israel
  • Kuwait Pharmaceutical Association
  • Pharmaceutical Association of Mauritius
  • Pharmaceutical Society of New Zealand
  • Norwegian Pharmacy Association
  • Pakistan Pharmacists Association
  • National Pharmacy Association
  • Pharmaceutical Society of Northern Ireland
  • Royal Pharmaceutical Society (RPS)
  • American Association of Colleges of Pharmacy (AACP)
  • American Pharmacists Association (APhA)
  • American Society for Pharmacy Law
  • American Society of Consultant Pharmacists (ASCP)
  • American Society of Consultant Pharmacists Foundation
  • American Society of Health-System Pharmacists (ASHP)
  • Professional Compounding Centers of America
  • American College of Clinical Pharmacy (ACCP)

List of Pharmaceutical Companies in Dubai:

  • Pharmaceutical companies in Dubai
  • Life Pharma FZE
  • Pharma Service Company
  • Globalpharma – A Sanofi Company
  • Pfizer
  • Pharmatrade L.L.C.
  • Clinart International
  •  Aster (Aster One) Pharmacy
  • IDS – Al Ittihad Drug Store
  • Genpharm
  • Ranbaxy Laboratories Limited
  • BioPharma
  • GlaxoSmithKline      
  • Gulf Inject
  • Saga Pharmaceuticals
  • Global Pharma
  • Astra Zeneca UAE    
  • Neopharma
  • Baxter A.G   
  • Medpharma

List of Pharmaceutical Companies in UAE:

  • Neopharma
  • Modern Pharmaceutical Company
  • Life Pharma FZE
  • Modern Pharmaceutical Company
  • Abu Dhabi International Medical Services(ADI)
  • Medisal Pharmaceuticals Industry L.L.C
  • UltraMed – Ultra Medical Stores
  • Propharma Medical Supplies
  • Al Hayat Pharmaceuticals company
  •  Al Razi Pharmacy Company LLC

List of Pharmaceutical Companies in the World:

  • Novartis
  • SMS Pharmaceuticals Ltd
  • Hetero
  • Astra Zeneca
  • Pfizer
  • Roche
  • Sanofi
  • Merck & Co.
  • Johnson & Johnson
  • GlaxoSmithKline
  • Novo Nordisk
  • Procter & Gamble
  • Purdue Pharma
  • Sun Pharmaceutical
  • Takeda Pharmaceutical Co.
  • Teva Pharmaceuticals
  • Torrent Pharmaceuticals
  • Vertex Pharmaceuticals
  • Wockhardt
  • Intas Biopharmaceuticals
dubai-city-images-6
maxresdefault
dubai-marina-dubay-oae
dubaibioexpo2016-75138
1451624366188
razoBg